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Abstract
Background: Two major ways of macrophage (MF) activation can occur in radiation-induced pulmonary injury
(RPI): classical and alternative MF activation, which play important roles in the pathogenesis of RPI. MF can
produce chemokine MF inflammatory protein-1a (MIP-1a), while MIP-1a can recruit MF. The difference in the
chemotactic ability of MIP-1a toward distinct activated MF is unclear. We speculated that there has been
important interaction of MIP-1a with different activated MF, which might contribute to the pathogenesis of RPI.
Methods: Classically and alternatively activated MF were produced by stimulating murine MF cell line RAW 264.7
cells with three different stimuli (LPS, IL-4 and IL-13); Then we used recombinant MIP-1a to attract two types of
activated MF. In addition, we measured the ability of two types of activated MF to produce MIP-1a at the protein
or mRNA level.
Results: Chemotactic ability of recombinant MIP-1a toward IL-13-treated MF was the strongest, was moderate for
IL-4-treated MF, and was weakest for LPS-stimulated MF (p < 0.01). The ability of LPS-stimulated MF to secrete
MIP-1a was significantly stronger than that of IL-4-treated or IL-13-treated MF (p < 0.01). The ability of LPS-
stimulated MF to express MIP-1a mRNA also was stronger than that of IL-4- or IL-13-stimulated MF (p < 0.01).
Conclusions: The chemotactic ability of MIP-1a toward alternatively activated MF (M2) was significantly greater
than that for classically activated MF (M1). Meanwhile, both at the mRNA and protein level, the capacity of M1 to
produce MIP-1a is better than that of M2. Thus, chemokine MIP-1a may play an important role in modulating the
transition from radiation pneumonitis to pulmonary fibrosis in vivo, through the different chemotactic affinity for
M1 and M2.
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Background
Radiation-induced pulmonary injury (RPI) can occur
during radiotherapy for thoracic cancer and limits the
radiation dose that can be applied. Although the histo-
pathological features of RPI have been well documented,
its pathogenesis has not been elucidated. Many types of
inflammatory cells are involved in RPI, but pulmonary
macrophages (MF) are the most prominent [1]. Differ-
ent populations of activated MF can arise in response
to distinct stimuli. When stimulated by lipopolysacchar-
ide (LPS) and/or IFN-g, the classically activated MF
(M1) is generated, which secretes high levels of proin-
flammatory cytokines and mediators [2], and expresses
inducible NO synthase (iNOS) [3]. M1 may enhance the
microbicidal activity of MF and is closely associated
with radiation pneumonitis. The amount of MF in the
lung increases quickly after irradiation [2]. The second
population of activated MF is alternatively activated
MF (M2) that arises in the presence of the cytokines
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the expression of mannose receptors [4], decreases the
antigen-presenting capability of MF,a n ds h o w sh i g h
arginase 1 activity [3]. Arginase 1 can contribute to the
production of ECM by catalyzing the formation of poly-
amines and collagen, overexpression of which improves
pulmonary fibrosis. Excessive IL-4 and the related M2
have been observed in radiation pulmonary fibrosis
(RPF) [2].
A variety of inflammatory cells play significant roles in
RPI, and chemokines also have non-redundant roles of
recruiting MF and other effector cells to the sites of
inflammatory injury [4]. Chemokines, especially macro-
phage inflammatory protein-1a (MIP-1a,a l s ok n o w na s
CCL3) and related CC-chemokines, act as signal trans-
ducers in inflammatory injury, and perform important
regulatory functions [5]. MIP-1a is thought to arise
mainly from MF and epithelial cells in the lung. Differ-
ent activated MF have different behavior related to
MIP-1a secretion. M1 stimulated by LPS and IFN-g
promotes MIP-1a-generation, while IL-4 and IL-10 inhi-
bit MIP-1a production of MF induced by LPS or IL-1b
[6,7]. MIP-1a, which possesses strong chemotactic affi-
nity for MF, is a critical MF chemoattractant in murine
wound repair [8,9].
The hypothesis of a perpetual cascade of cytokines
leading to RPI is a reasonable explanation [10]. However,
the hypothesis does not specify which cell or cytokine
dominates in the cascade response. The mechanism of
the transition from radiation pneumonitis to RPF also is
unknown, as is whether the chemotactic affinity of MIP-
1a is different for distinct activated MF. We speculate
that MIP-1a arises mainly from M1, while its
chemotactic affinity toward M2 is stronger than for M1.
The interaction between MIP-1a and MF in different
activated states may play a crucial role in regulating the
transition from radiation pneumonitis to RPF. By con-
structing classically and alternatively activated models of
MF induced by different stimuli (LPS, IL-4 and IL-13),
the interaction between MIP-1a and different activated
MF was studied in vitro to investigate the pathogenesis
of RPI.
Materials and methods
Macrophage culture
The murine MF cell line RAW 264.7 was obtained from
the China Center for Type Culture Collection (CCTCC)
at Wuhan University, and grown in DMEM supplemen-
ted with 10% heated-inactivated FCS, 2 mmol/L L-gluta-
mine, and 100 U/mL penicillin/streptomycin (GIBCO)
at 37ºC in a humidified incubator of 5% CO2. For some
experiments, cells were starved, which means that cells
were washed with phosphate-buffered saline (PBS) and
incubated in DMEM supplemented with 100 U/mL
penicillin/streptomycin for 12 h, but without 10%
heated-inactivated FCS or 2 mmol/L L-glutamine. Cells
between passages 5 and 20 were used in this study.
Experimental design
Cells were plated in 24-well plates (for nitrite [NO2
-]o r
urea measurements) at 5 × 10
5 cells/well. When the
cells fully adhered after starvation for 12 hours, they
were exposed to 30 ng/mL LPS (Sigma), IL-4 (Pepro-
Tech), or IL-13 (PeproTech), respectively. At the sched-
uled time points (see Figures 1A, 2A, C), the
supernatant from the cells stimulated by LPS was
Figure 1 NO production of RAW 264.7 cells stimulated by LPS. A. RAW cells were exposed to either 0 ng/mL or 30 ng/mL LPS. At
scheduled time points, the cell supernatant was collected for determination of NO2
- with Griess reagent. B. RAW cells were exposed to LPS for
48 h at different concentrations, then NO2
- was measured in the same way as in A. Values are averages ± SD of two independent experiments
each done in triplicates; (**) indicates p < 0.01, (one way ANOVA).
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- measurement using the colorimetric
Griess reaction [11]; cells stimulated by IL-4 or IL-13
were gathered to for urea measurement using a micro-
plate method [12]. The best incubation time was deter-
mined by the preceding time points. Cells were plated
and starved in the same way again, then exposed to
LPS, IL-4, or IL-13 at seven different concentrations
(see Figures 1B, 2B, D). After incubation, measurement
of NO2
- was done for LPS-stimulated samples and mea-
surement of urea was done for IL-4- or IL-13-treated
samples to determine the best concentration for
stimulus.
Cells were then plated in a culture flask at 5 × 10
5 cells/
mL × 6 mL, for the chemotaxis assay, or in 60-mm dishes
at 5 × 10
5 cells/mL × 3 mL for measurement of protein
expression of MIP-1a from the cell supernatant, or for
detection of MIP-1a mRNA in the cells. Optimal concen-
trations of LPS, IL-4, or IL-13, as determined by the earlier
experiments, were used to determine the best times.
Measurement of nitric oxide
The production of NO was measured by determining
NO2
- in the culture supernatants using the colorimetric
Griess reaction. Aliquots (60 μL) of cell supernatant
were combined with an equal volume of Griess reagent
[1% sulfanilamide (Alfa Aesar)/0.1% N-(1-napthyl) ethy-
lenediamine (International Laboratory USA) – each in
2.5% H3PO4] in a 96-well plate at room temperature for
10 min, and the absorbance at 550 nm was measured
with a Multiscan plate reader (Genios, Tencan). Absor-
bance measurements were averaged and converted to
μmol/L of NO2
- per well using a standard curve of
sodium nitrite.
Determination of arginase activity
Arginase activity was determined according to a micro-
plate method with slight modification. After incubation
for the scheduled time, the cells were rinsed with PBS,
then lysed with 300 μL of 0.5% Triton X-100 that con-
tained protease inhibitors (Sigma). After shaking for 30
min at room temperature, the lysate was mixed with
400 μL of 25 mmol/L Tris-HCL (pH 7.4) and 100 μLo f
10 mmol/L MnCl2. The arginase was activated by heat-
ing for 10 min at 56ºC. Arginine hydrolysis to urea was
conducted by addition of 50 μL of 0.5 mol/L L-arginine
(pH 9.7) to 50 μL of the activated lysate, followed by
Figure 2 Urea production of RAW 264.7 cells by IL-4 or IL-13.R A Wc e l l sw e r ee x p o s e dt o0n g / m L ,3 0n g / m LL P S ,3 0n g / m LI L - 4( s e e
Figure 2A) or 30 ng/mL IL-13 (see Figure 2C). At scheduled time points, the cells were collected for urea determination using a microplate
method. RAW 264.7 cells were exposed to IL-4 for 12 h (see Figure 2B) or IL-13 for 8 h (see Figure 2D) at different concentrations, then urea was
measured. Values are averages ± SD of two independent experiments each done in triplicates; (*) indicates p < 0.05, (**) indicates p < 0.01 (one
way ANOVA).
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stopped with 800 μLo fH 2SO4 (96%)/H3PO4 (85%)/H2O
(1/3/7, v/v/v). Urea concentration was measured at 550
nm after addition of 50 μL of 9% (w/v) a-isonitrosopro-
piophenone (Tokyo Chemical Industry Co. LTD) dis-
solved in 100% ethanol and heating at 100ºC for 45 min.
A standard curve was created using two-fold dilutions of
urea (1.25 μg/mL to 640 μg/mL) following by mixing
with the stop reagent and then heating.
Chemotaxis assay
The ability of rMIP-1a (PeproTech) to promote MF
chemotaxis was measured with a 24-well Transwell
chamber (Sigma). When the MF in the culture flask
was stimulated, it was washed twice with PBS and sus-
pended in DMEM at a concentration of 5 × 10
5 cells/
mL. A series of MIP-1a or DMEM alone (negative con-
t r o l )( s e eF i g u r e3 )w e r ep l a c e di nt h eb o t t o mw e l l so f
the chemotaxis chamber and 8- μm thick polycarbonate
filters were placed on top of the wells. MF suspensions
(200 μL) were placed on the top of wells and the cham-
ber was incubated at 37ºC for 120 min. The filters were
removed and nonmigrating cells (facing the top wells)
were gently washed off with PBS and then air-dried.
After staining MF with 150 uL of crystal violet, cell
counts were determined using a light microscope to
compare the strength of the chemotactic affinity.
MIP-1a measurement by ELISA
Extracellular immunoreactive MIP-1a was measured by
ELISA using a commercial kit (R&D) according to the
manufacturer’s instructions. Sample absorbance was
measured with a Multiscan plate reader (Genios, Ten-
can) at a wavelength of 450 nm. The sample concentra-
tion was measured using a standard curve.
Real-time quantitative PCR of MIP-1a
Total cellular RNA was extracted using Trizol according
to the manufacturer’s instructions. Then RNA was
reverse-transcripted into cDNA using reverse-transcrip-
tase (Toyobo). For amplification by PCR, the forward
primer for MIP-1a was CTCCCAGCCAGGTGTCATT,
and the reverse primer was GGCATTCAGTTC-
CAGGTCAG. The forward primer for b-actin was
CCGTGAAAAGATGACCCAG, and the reverse primer
was TAGCCACGCTCGGTCAGG. The PCR conditions
were as follows: 95ºC, 45 sec; 60ºC, 15 sec; 72ºC, 45 sec
for 40 cycles. Amplification was terminated by 10 min
at 72ºC. For data analysis, the comparative threshold
cycle (CT) value for b-actin was used to normalize load-
ing variations in the real-time PCRs. ΔΔCT value then
was obtained by subtracting the control ΔCT values
from the corresponding experimental ΔCT values. The
ΔΔCT values were compared with the control by raising
two to the ΔΔCT power.
Statistical analysis
Statistical analyses of data were conducted using one-
way analysis of variance (ANOVA). Statistical signifi-
cance was established at p < 0.05. The software used for
statistical analysis was SPSS 13.0 (SPSS, Inc., Chicago,
IL).
Results
Expression of macrophage enzyme activity
To obtain activated states of MF,M F was stimulated
by LPS, IL-4, and IL-13, and then the activated states
were evaluated by measuring iNOS and arginase activity.
M1 induced by LPS expressed specific iNOS activity,
while M2 stimulated by IL-4 or IL-13 showed particular
arginase1 activity. Therefore, the magnitude of iNOS or
arginase activity was chosen to reflect the strength of
classically or alternatively activated states of MF.
Experimental results demonstrated that, compared
with iNOS activity of quiescent MF, the activity in MF
increased significantly after MF was stimulated by LPS
(30 ng/mL) for 12 hours (p < 0.01), and peaked at 48
hours (see Figure 1A). When stimulated with various
concentrations for a fixed time (48 h), MF induced by
60 ng/mL LPS expressed the greatest iNOS activity (see
Figure 1B). Compared with arginase activity of quiescent
and LPS-stimulated MF, arginase activity was increased
significantly when MF was treated by IL-4 (30 ng/mL)
within 24 hours (p < 0.01) or by IL-13 (30 ng/mL)
within 12 hours (p < 0.01). The quiescent and LPS-sti-
mulated MF also expressed arginase activity. In
Figure 3 Recombinant MIP-1a as a potent chemoattractant for
MF in vitro. Cells were exposed to 60 ng/mL LPS for 48 h, 40 ng/
mL IL-4 for 12 h, or 60 ng/mL IL-13 for 8 h, followed by cell
collection. MF chemotaxis was measured in a Transwell chamber
with rMIP-1a at several concentrations. Results are expressed as cell
number/horizon under a light microscope (250 times) Values are
averages ± SD done in triplicates; Significant difference (p < 0.01) of
chemotactic ability was obvious for different activated states of MF
(one way ANOVA).
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LPS for 36 hours resulted in an increase of arginase
expression (p > 0.05), but significantly less than the activity
resulting from MF stimulated by IL-4 within 24 hours, or
MF stimulated by IL-13 within 12 hours (see Figures 2A,
C). When stimulated with different concentrations at a
fixed time, MF induced by 40 ng/mL IL-4 or 60 ng/mL
IL-13 showed the greatest arginase activity (see Figures 2B,
D). Thus, the optimal conditions were stimulation of clas-
sically activated MF with 60 ng/mL LPS for 48 hours, sti-
mulation of alternatively activated MF with 40 ng/mL IL-
4 for 12 hours, and stimulation of alternatively activated
MF with 60 ng/ml IL-13 for 8 hours.
These results provide further information about the
factors involved in arginase activity from alternative
macrophages. In contrast with a previous report of urea
production from different activated MF [10], the pre-
sent results showed that urea production of the cells
produced a bell-shaped response with both IL-4 and IL-
13 at different stimulation times or concentrations (see
Figure 2). This difference was attributed to the experi-
mental conditions that were repeatedly explored in the
pre-experimental phase, and represents a change in argi-
nase activity of RAW 264.7, indicating that stimulation
time and concentration of the stimulus both signifi-
cantly affect enzyme activity.
Chemotactic ability of MIP-1a toward activated
macrophages
A difference in the chemotactic ability of MIP-1a for dif-
ferent activated MF was verified. This difference was
reflected in two ways. First, chemotactic ability was
distinct for different activated states of MF (p < 0.01).
Chemotactic ability of MIP-1a toward IL-13-treated MF
was the strongest, was moderate for IL-4-treated MF,a n d
was weakest for LPS-stimulated MF. Second, the peak
concentration of MIP-1a for different activated MF also
was different, with a peak concentration for IL-13-stimu-
lated MF of 5 ng/mL, but a peak concentration for IL-4-
and LPS-stimulated MF of 10 ng/mL (see Figure 3).
Comparison of macrophages producing MIP-1a
The capacity of MIP-1a production for different acti-
vated MF varied. MIP-1a production of quiescent MF
at different time points was not statistical different (p >
0.05) at the mRNA or protein level. At the protein level,
MIP-1a expression from cell supernatants was deter-
mined by ELISA. The ability of LPS-stimulated MF to
secrete MIP-1a was significantly stronger than that of
IL-4-treated or IL-13-treated MF (p < 0.01). Compared
with untreated quiescent MF, the MF stimulated by IL-
4 or IL-13 produced lower levels of MIP-1a secretion
(see Figure 4A). At the mRNA level, MIP-1a expression
from cells was determined by RT-PCR. The ability of
LPS-stimulated MF to express MIP-1a mRNA also was
stronger than that of IL-4- or IL-13-stimulated MF (p <
0.01) (see Figure 4B). Therefore, we conclude that at the
level of either protein or mRNA, MF stimulated by LPS
was able to express MIP-1a significantly better than
MF stimulated by IL-4 or IL-13.
Discussion
The interaction between chemokines and macrophages is
complex, which significantly affects macrophage biological
Figure 4 Induction of MIP-1a expression in RAW 264.7 cells. A. RAW cells were exposed either to 60 ng/mL LPS for 48 h, 40 ng/mL IL-4 for
12 h, or 60 ng/mL IL-13 for 8 h, followed by culture supernatant collection. Supernatant MIP-1a was assayed by ELISA. B. RNA was extracted
from RAW cells treated as shown in A. MIP-1a mRNA levels were quantified using real-time RT-PCR, with an 8h control group. b-actin was used
as an internal control. Calculation of fold values is described in Materials and Methods. Values are averages ± SD of two independent
experiments each done in triplicates; (**) indicates p < 0.01 (one way ANOVA).
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the chemotactic ability of MIP-1a toward M2 is signifi-
cantly stronger than that for M1, while the capacity of M1
to produce MIP-1a is better than that of M2.
However, little information existed about whether a
difference exists in the chemotactic ability of MIP-1a
for different activated MF. Several groups have reported
there is a preferential attraction of certain subsets of
lymphocytes by human MIP-1a [13,14], MIP-1a is a
potent chemoattractant for MF.B yc h e m o k i n eb i n d i n g
to cell surface CC chemokine receptors of MF,w h i c h
belong to the G-protein-coupled receptor superfamily,
the G-protein complex can induce Ca
2+ from extracellu-
lar and smooth endoplasmic reticulum influx into cyto-
plasm [15]. An increase in Ca
2+ in cytoplasm is
necessary for MF migration. The results of our experi-
ments indicate that the chemotactic ability of MIP-1a
for M2 is significantly stronger than that for M1. LPS
could rapidly inhibit expression of CC chemokine recep-
tors by reduction of CCR1 mRNA levels in monocytes
[16]. A distinct stimulus leading to differences in the
properties and numbers of CC chemokine receptors in
activated MFs may contribute to the chemotactic ability
disparity of MIP-1a for activated MF.
And there are mininal effective and maximal concen-
trations for human MIP-1a’s chemotaxis. Human MIP-
1a was found to chemoattract NK cells in vitro,a n d
maximal activity was obtained at a concentration of
100-1000 ng/ml [17,18]. Our results may confirm a
similar conclusion. At the concentration range of 8-18
ng/ml, MIP-la shows maximum chemotactic activity for
different activated macrophages.
Many cells, especially MF, can express low levels of
MIP-1a constitutively, which can be induced or inhib-
ited by regulators. The same regulator may exert an
opposite effect on different cells. For example, IL-4 and
IL-10 inhibit MIP-1a production of MF stimulated by
LPS or IL-1b, while IL-4, IL-10, INF-g,a n dI L - 1 b all
induce vascular smooth muscle cells to produce MIP-1a
[19]. Our experiments indicated that, at the mRNA and
protein level, the ability of MF stimulated by LPS to
secrete MIP-1a is significantly greater than that of MF
stimulated by IL-4 or IL-13. Thus, the ability of M1 to
produce MIP-1a is better than that of M2. The ability
of M2 induced by IL-4 or IL-13 to produce MIP-1a is
only slightly enhanced when compared to the control
group, which seems to contradict IL-4 inhibition of
LPS-induced MIP-1a secretion. This phenomenon may
result from a difference in the original activated states
of MF.
Different activated MF in RPI are induced by distinct
cytokines generated by damaged cells after g-ray irradia-
tion of the lung. Classical activation of macrophages was
originally reported to require both TNF-a and IFN-g
[20]. Bacterial endotoxin LPS was chosen as a stimulus
for murine MF cell line RAW 264.7 cells to generate
M1 in this study because LPS (a Toll-like receptor ago-
nist) stimulates MF in an autocrine manner to induce
both TNF and IFN-b and activate MF [21]. IFN-g, LPS,
and IFN-g +LPS are weak, moderate, and strong indu-
cers of iNOS activity, respectively, in in vitro experi-
ments [22], so single stimulus LPS was best at inducing
M1, when compared to other single inducers.
The M2 designation encompasses cells with differ-
ences in their biochemical and physiological activity
[23]. People have attempted to further subdivide this
type of MF, but a way to classify them further has not
been developed. When stimulated by IL-4 and/or IL-13,
MF can develop into alternatively activated (M2a). M2
can be further subdivided into those induced by
immune complexes (ICs) and LPS or IL-1b (M2b) or
those induced by IL-10, TGF-b, or glucocorticoids
(M2c). However, one researcher [24] proposed that M2b
and M2c belonged to a subtype of activated macro-
phages that required two stimuli to induce their anti-
inflammatory activity. In our experiment, we select M2a
as the alternative activated subtype because it is involved
in injury repair and has been studied extensively.
Previous studies often have used a fixed-dose stimulus
acting for a fixed time to generate activated MF [25].
Measuring enzyme activity of biomarkers iNOS and
arginase 1 can reflect the strength of the biological
activity of activated MF. Our study suggests that the
biological activity of activated MF is different when
induced by stimuli at different doses for different times.
Therefore, the conditions that produce the optimal acti-
vation of MF in vitro must be investigated. The results
of our experiments also show that M1 expresses argi-
nase activity that is significantly weaker than that of
M2a. Results of a previous study also demonstrated that
arginase expression could be triggered by IL-4 and IL-
10 as well as by detoxified LPS, while IFN-g induced
only NO synthesis in macrophages in vitro [26].
In conclusion, our data indicate that the chemotactic
ability of MIP-1a for M2 is significantly stronger than
for M1, while the capacity of M1 to produce MIP-1a is
better than that of M2. RPI is a multi-cell and multi-
cytokine-mediated cascading event, many cytokines such
as TNF-a may play an important role in the process of
RPI [27], but they could not completely explain its
pathogenesis. The important roles of macrophages at
different stages of RPI and the interactions between
macrophages and chemokines may mean that chemo-
kines could be key factors in the pathogenesis of RPI
through chemotactic disparity of different cells, or even
different subtypes of the same cell. Blocking the expres-
sion of MIP-1a or inhibiting its chemotactic ability
could control the degree of repair in vivo, which may be
He et al. Radiation Oncology 2011, 6:86
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Page 6 of 7a promising method of preventing RPI. Studies are con-
tinuing to examine the interactions between different
activated MF and MIP-1a in an RPI mouse model, and
their role in the pathogenesis of RPI.
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